Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
Saved in:
| Title: | Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD. |
|---|---|
| Authors: | Click B; Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, USA., Barnes EL; University of North Carolina, Chapel Hill, USA., Cohen BL; Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, USA., Sands BE; Mount Sinai, New York, USA., Hanson JS; Atrium Health, Charlotte, USA., Rubin DT; University of Chicago, Chicago, USA., Dubinsky MC; Mount Sinai, New York, USA., Regueiro M; Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, USA., Gazis D; Target RWE Health Evidence Solutions, 2520 Meridian Pkwy, Suite 105, Durham, NC, 27713, USA., Crawford JM; Target RWE Health Evidence Solutions, 2520 Meridian Pkwy, Suite 105, Durham, NC, 27713, USA. jcrawford@targetrwe.com., Long MD; University of North Carolina, Chapel Hill, USA. |
| Source: | BMC gastroenterology [BMC Gastroenterol] 2022 Feb 19; Vol. 22 (1), pp. 71. Date of Electronic Publication: 2022 Feb 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-230X |
|---|---|
| DOI: | 10.1186/s12876-022-02143-x |
